** Shares of Heska Corp HSKA.O fall 9.9% to $90.88,
hitting lowest since August 2020
** HSKA, which sells veterinary diagnostic and specialty
healthcare products, reports Q1 net loss of nearly $10 mln vs
profit of $1.9 mln the prior year urn:newsml:reuters.com:*:nPnpvmyQa
** Co's operating expenses surge 66% from last year, driven
by higher investment in research and development
** HSKA's Q1 revenue rises about 7% to $64.8 mln, but misses
Refinitiv IBES estimates of $65.9 mln
** Of the 6 analysts covering the stock, 3 rate it "buy" and
3 "hold"; their median PT is $175.5 - Refinitiv data
** Stock has halved in value YTD
(Reporting by Amruta Khandekar)
((Amruta.Khandekar@thomsonreuters.com;))